The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Major depression and its treatment: microRNAs as peripheral biomarkers of diagnosis and treatment response
Abstract
PURPOSE OF REVIEW: Major depressive disorder (MDD) is among the most prevalent and disabling medical conditions worldwide. Despite its considerable burden, our understanding of its pathophysiology remains rudimentary, and a validated biomarker has yet to be identified. Antidepressants are the most common treatment for MDD, yet roughly one-third of patients experience an inadequate response. Thus, there is a great need for not only identifying biomarkers of MDD but also those that can predict and monitor or just monitor response to treatment. RECENT FINDINGS: MicroRNAs (miRNAs) act as endogenous fine-tuners and on-off switches of gene expression. Several lines of evidence now suggest that miRNAs are involved in the pathogenesis of neuropsychiatric disorders. As such, miRNAs offer great hope as biomarkers of disease and response to treatment. SUMMARY: In this review, we discuss the growing field, investigating peripheral miRNAs as potential biomarkers of major depression and treatment response. A noninvasive and validated biomarker of MDD or treatment response will help clinicians guide treatment selection. Ultimately, these findings provide important steps in the development of early diagnostic tools, preventive strategies, and effective pharmacological treatment for psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This highlights miRNAs’ potential as biomarkers for treatment response; however, further studies are needed.”
From Epigenetics and depression (2019) · cites this paper as [31]
In the citing paper
“Other studies of postmortem brain and peripheral tissues have identified altered levels of miRNAs in patients with MDD and after treatment with antidepressant medication (see ref 31 for a review).”
From Epigenetics and depression (2019) · cites this paper as [31]
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Regulation of microRNA biogenesis
Ha, M., & Kim, V. N. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3838 · Cited by 5,462
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930
Non-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“In addition, several lines of evidence suggest that that MDD is a systemic illness(64, 65), so even if peripheral samples would not be good surrogates of the CNS, there is still value to study peripheral samples per se because we could detect peripheral processes that may be etiologically relevant…”
BackgroundInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Vickers, K. C., Palmisano, B. T., Shoucri, B. M., Shamburek, R. D., & Remaley, A. T. (2011) · Nature Cell Biology · doi:10.1038/ncb2210 · Cited by 2,741
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
The Landscape of long noncoding RNA classification
Laurent, G. S., Wahlestedt, C., & Kapranov, P. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.03.007 · Cited by 1,211
The Long and Short of MicroRNA
Yates, L. A., Norbury, C. J., & Gilbert, R. J. C. (2013) · Cell · doi:10.1016/j.cell.2013.04.003 · Cited by 712
Evaluating the comparability of gene expression in blood and brain
Sullivan, P. F., Fan, C., & Perou, C. M. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30272 · Cited by 581
Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease
Qureshi, I., & Mehler, M. F. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3234 · Cited by 578
Perkins, D. O., Jeffries, C. D., Jarskog, L. F., Thomson, J. M., Woods, K., Newman, M. A., Parker, J. S., Jin, J., & Hammond, S. M. (2007) · Genome Biology · doi:10.1186/gb-2007-8-2-r27 · Cited by 574
MiR-16 Targets the Serotonin Transporter: A New Facet for Adaptive Responses to Antidepressants
Baudry, A., Mouillet-Richard, S., Schneider, B., Launay, J.-M., & Kellermann, O. (2010) · Science · doi:10.1126/science.1193692 · Cited by 480
Domenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S. L., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009166 · Cited by 353
Smalheiser, N. R., Lugli, G., Rizavi, H. S., Torvik, V. I., Turecki, G., & Dwivedi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033201 · Cited by 324
Self-citationGlatt, S. J., Everall, I., Kremen, W. S., Corbeil, J., Šášik, R., Khanlou, N., Han, M., Liew, C., & Tsuang, M. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507666102 · Cited by 322
Issler, O., Haramati, S., Paul, E. D., Maeno, H., Navon, I., Zwang, R., Gil, S., Mayberg, H. S., Dunlop, B. W., Menke, A., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.042 · Cited by 318
Determining the role of microRNAs in psychiatric disorders
Issler, O., & Chen, A. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3879 · Cited by 309
Lopez, J. P., Lim, R., Cruceanu, C., Crapper, L., Fasano, C., Labonte, B., Maussion, G., Yang, J. P., Yerko, V., Vigneault, E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3582 · Cited by 308
Self-citationLakhal, S., & Wood, M. J. A. (2011) · BioEssays · doi:10.1002/bies.201100076 · Cited by 271
Tsuang, M. T., Nossova, N., Yager, T. D., Tsuang, M., Guo, S., Shyu, K. G., Glatt, S. J., & Liew, C. C. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30161 · Cited by 239
Blood microRNA changes in depressed patients during antidepressant treatment
Bocchio-Chiavetto, L., Maffioletti, E., Bettinsoli, P., Giovannini, C., Bignotti, S., Tardito, D., Corrada, D., Milanesi, L., & Gennarelli, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.013 · Cited by 238
Belzeaux-R, R., Bergon, A., Jeanjean, V., Loriod, B., Formisano‐Tréziny, C., Verrier, L., Loundou, A., Baumstarck, K., Boyer, L., Gall, V., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.112 · Cited by 227
Identification of differentially expressed microRNAs across the developing human brain
Ziats, M. N., & Rennert, O. M. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.93 · Cited by 214
Translating Pharmacogenomics: Challenges on the Road to the Clinic
Swen, J. J., Huizinga, T. W. J., Gelderblom, H. A. J., de Vries, E. G. E., Assendelft, W. J., Kirchheiner, J., & Guchelaar, H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040209 · Cited by 209
Depression as a systemic syndrome: mapping the feedback loops of major depressive disorder
Wittenborn, A. K., Rahmandad, H., Rick, J., & Hosseinichimeh, N. (2016) · Psychological Medicine · doi:10.1017/s0033291715002044 · Cited by 207
Lopez, J. P., Fiori, L. M., Cruceanu, C., Lin, R., Labonte, B., Cates, H. M., Heller, E. A., Vialou, V., Ku, S. M., Gerald, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms15497 · Cited by 201
Self-citationIdentification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder
Roy, B., Dunbar, M., Shelton, R. C., & Dwivedi, Y. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.175 · Cited by 199
Smalheiser, N. R., Lugli, G., Zhang, H., Rizavi, H. S., Cook, E. H., & Dwivedi, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086469 · Cited by 196
MicroRNA dysregulation in psychiatric disease
Miller, B. H., & Wahlestedt, C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.035 · Cited by 185
Wan, Y., Liu, Y., Wang, X., Wu, J., Liu, K., Zhou, J., Liu, L., & Zhang, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121975 · Cited by 182
Peripheral whole blood microRNA alterations in major depression and bipolar disorder
Maffioletti, E., Cattaneo, A., Rosso, G., Maina, G., Maj, C., Gennarelli, M., Tardito, D., & Bocchio-Chiavetto, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.021 · Cited by 181
Torres-Berrío, A., Lopez, J. P., Bagot, R. C., Nouel, D., Dal Bo, G., Cuesta, S., Zhu, L., Manitt, C., Eng, C., Cooper, H. M., et al. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.08.017 · Cited by 153
Self-citationon behalf of the CAN-BIND Investigator Team, Lam, R. W. M., Milev, R. V., Rotzinger, S., Andreazza, A. C., Blier, P., Brenner, C. A., Daskalakis, Z. J., Dharsee, M., Downar, J. H., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0785-x · Cited by 152
Self-citationMicroRNAs as biomarkers for major depression: a role for let-7b and let-7c
Gururajan, A., Naughton, M., Scott, K. A., O’Connor, R. M., Moloney, G. M., Clarke, G. A., Dowling, J. L., Walsh, A. E. L., Ismail, M. F., Shorten, G., et al. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.131 · Cited by 150
Fan, H., Sun, X., Guo, W., Zhong, A., Niu, W., Zhao, L., Dai, Y.-H., Guo, Z.-M., Zhang, L.-Y., & Lu, J. Z. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.08.007 · Cited by 129
MicroRNA pharmacogenomics: Post-transcriptional regulation of drug response
Rukov, J. L., & Shomron, N. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.04.003 · Cited by 126
Raphe-mediated signals control the hippocampal response to SRI antidepressants via miR-16
Launay, J., Mouillet‐Richard, S., Baudry, A., Pietri, M., & Kellermann, O. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.54 · Cited by 123
Camkurt, M. A., Acar, Ş. T., Coşkun, S., Güneş, M., Güneş, S., Yılmaz, M. F., Görür, A., & Tamer, L. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.07.023 · Cited by 115
Song, M.-F., Dong, J., Wang, Y.-W., He, J., Ju, X., Zhang, L., Zhang, Y., Shi, J., & Lv, Y.-Y. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.02.022 · Cited by 111
MicroRNAs in psychiatric and neurodevelopmental disorders
Xu, B., Karayiorgou, M., & Gogos, J. A. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.109 · Cited by 103
Lopez, J. P., Fiori, L. M., Gross, J. A., Labonte, B., Yerko, V., Mechawar, N., & Turecki, G. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000941 · Cited by 103
Self-citationMicroRNAs in Mental Health: From Biological Underpinnings to Potential Therapies
Hunsberger, J. G., Austin, D. R., Chen, G., & Manji, H. K. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8070-5 · Cited by 99
Hu, W., & Coller, J. (2012) · Cell Research · doi:10.1038/cr.2012.80 · Cited by 98
Mouillet‐Richard, S., Baudry, A., Launay, J., & Kellermann, O. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.035 · Cited by 98
He, S., Liu, X., Jiang, K., Peng, D., Hong, W., Fang, Y., Qian, Y., Yu, S., & Li, H. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.015 · Cited by 94
Su, M., HONG, J., ZHAO, Y., Liu, S., & XUE, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4104 · Cited by 93
Maussion, G., Yang, J., Yerko, V., Barker, P., Mechawar, N., Ernst, C., & Turecki, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039301 · Cited by 91
Self-citationAzevedo, J. A., Carter, B. S., Meng, F., Turner, D. L., Dai, M., Schatzberg, A. F., Barchas, J. D., Jones, E. G., Bunney, W. E., Myers, R., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.012 · Cited by 84
Pharmacogenomics: The Promise of Personalized Medicine for CNS Disorders
de León, J. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.147 · Cited by 81
The Canadian Biomarker Integration Network in Depression (CAN-BIND): Advances in Response Prediction
Kennedy, S. H., Downar, J. H., Evans, K., Feilotter, H. E., Lam, R. W. M., MacQUEEN, G. M., Milev, R. V., Parikh, S. V., Rotzinger, S., & Soares, C. N. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212803523635 · Cited by 77
Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease
Kocerha, J., Dwivedi, Y., & Brennand, K. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.30 · Cited by 76
Sun, N., Lei, L., Wang, Y., Yang, C., Liu, Z., Li, X., & Zhang, K. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.01.017 · Cited by 74
ENĂTESCU, V. R., Papavă, I., Enătescu, I., Antonescu, M., Anghel, A., Șeclăman, E. P., Sîrbu, I. O., & Marian, C. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.5.549 · Cited by 74
Fiori, L. M., Lopez, J. P., Richard-Devantoy, S., Berlim, M., Chachamovich, E., Jollant, F., Foster, J., Rotzinger, S., Kennedy, S. H., & Turecki, G. (2017) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx034 · Cited by 71
Self-citationMaheu, M., López, J. P., Crapper, L., Davoli, M. A., Turecki, G., & Mechawar, N. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.11 · Cited by 62
Self-citationWeigelt, K., Bergink, V., Burgerhout, K. M., Pescatori, M., Wijkhuijs, A. J. M., & Drexhage, H. A. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.12.018 · Cited by 61
Lopez, J. P., Pereira, F., Richard-Devantoy, S., Berlim, M., Chachamovich, E., Fiori, L. M., Niola, P., Turecki, G., & Jollant, F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.9 · Cited by 50
Self-citationIncreased miR-132 level is associated with visual memory dysfunction in patients with depression
Liu, Y., Yang, X. Y., Zhao, L., Zhang, J., Li, T., & Ma, X. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s116287 · Cited by 38
Potential Use of MicroRNA for Monitoring Therapeutic Response to Antidepressants
Belzeaux-R, R., Lin, R., & Turecki, G. (2017) · CNS Drugs · doi:10.1007/s40263-017-0418-z · Cited by 38
Self-citationMicroRNA-326 acts as a molecular switch in the regulation of midbrain urocortin 1 expression
Aschrafi, A., Verheijen, J., Gordebeke, P. M., Loohuis, N. F. M. O., Menting, K. W., Jager, A., Palkovits, M., Geenen, B., Kos, A., Martens, G. J. M., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150154 · Cited by 32
Self-citationApplying small RNA molecules to the directed treatment of human diseases: realizing the potential
Pappas, T. C., Bader, A. G., Andruss, B. F., Brown, D., & Ford, L. P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.1.115 · Cited by 31
Depression, antidepressants, and peripheral blood components.
Fišar, Z., & Raboch, J. (2008) · PubMed · Cited by 30
Pharmacogenomics genes show varying perceptibility to microRNA regulation
Rukov, J. L., Vinther, J., & Shomron, N. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283438865 · Cited by 30
Dadkhah, T., Rahimi-Aliabadi, S., Jamshidi, J., Ghaedi, H., Taghavi, S., Shokraeian, P., Akhavan-Niaki, H., Tafakhori, A., Ohadi, M., & Darvish, H. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.10.008 · Cited by 26
Cited by
Sorted by citations
Penner-Goeke, S., & Binder, E. B. (2019) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2019.21.4/ebinder · Cited by 254
Wei, Z.-X., Xie, G.-J., Mao, X., Zou, X.-P., Liao, Y.-J., Liu, Q.-S., Wang, H., & Cheng, Y. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0622-2 · Cited by 227
Zhang, Y., Du, L., Bai, Y., Han, B., He, C., Gong, L., Huang, R., Shen, L., Chao, J., Liu, P., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0285-0 · Cited by 184
MicroRNA mediators of early life stress vulnerability to depression and suicidal behavior
Allen, L., & Dwivedi, Y. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0597-8 · Cited by 152
Epigenetic Regulations in Neuropsychiatric Disorders
Kuehner, J. N., Bruggeman, E. C., Wen, Z., & Yao, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00268 · Cited by 144
Metadata
- Authors
- Lopez, J. P., Kos, A., & Turecki, G.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Douglas Mental Health University Institute (CA)
- Corresponding author
- Turecki, Gustavo
- Venue
- Current Opinion in Psychiatry
- Published
- 2018-01
- Volume
- 31
- Issue
- 1
- Pages
- 7-16
- ISSN
- 0951-7367 (ISSN-L)
- OpenAlex
- W2766080306
- Cited by
- 108
- References
- 67
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 9 · 2023: 13 · 2022: 19 · 2021: 15 · 2020: 20 · 2019: 14 · 2018: 6
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@McGill (McGill) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, microRNA, biomarkers, antidepressant response, peripheral biomarkers, depression pathophysiology, treatment response prediction, early detection of depression
- MeSH terms
- Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Humans, Biomarkers, Treatment Outcome, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
